True North Advisors 13F: Cuts CME Stake by $708K

True North Advisors reduced its holdings in CME Group Inc. ticker CME by 65.4% during the third quarter, according to a Form 13F filing with the SEC on October 22, 2026. The institutional investor parted ways with a large portion of its investment during the period, shifting its strategy on the exchange operator. CME Group Inc. closed at $305.98 on the day of the filing.

CME CME Group Inc.

$305.98 ▲ +17.32% year to date

1M 3M YTD

Daily close · Oct 22, 2026

What Changed in True North Advisors's CME Group Inc. Position

True North Advisors sold 2,701 shares of CME Group Inc. during the quarter. That move brought its total holdings down to 1,429 shares. The remaining stake carried a value of about $374,369 at the time of the disclosure, following a 65.4% decrease from its prior position of 4,130 shares.

Other Institutional Activity in CME Group Inc.

Other institutional investors also adjusted their positions in the company around the same time. Carnegie Investment Counsel reduced its holdings by 7,393 shares, ending with 152,288 shares worth about $378,61906.0. Y-Intercept cut its stake by 95,086 shares to finish with 53,259 shares valued at $13,952,793. TCV Trust & Wealth Management opened a new position with 937 shares worth about $245,474. PineStone Asset Management trimmed its holdings by 109,200 shares, holding 2,610,147 shares valued at $683,806,311. Sagespring Wealth Partners lowered its stake by 5,482 shares, ending with 24,221 shares worth about $6,345,311.

CME Group Inc. Stock Up 0.8%

CME Group Inc. recently traded around $295.79. That price sits below its closing level of $305.98 on the filing date. The stock trades above both its 50-day moving average of $275.00 and its 200-day moving average of $278.92.

Recent Earnings

CME Group Inc. reported trailing-twelve-month revenue of $6,757,199,872 alongside earnings of $11.79 per share. The company operates with a net profit margin of 63.4% and a return on equity of 15.8%.

Dividend

CME Group Inc. pays an annual dividend rate of $5.20 per share, giving it a dividend yield of 1.76%. The company distributes 95.4% of its earnings as dividends.

Insider Buying and Selling at CME Group Inc.

Insiders traded company shares ahead of the filing. Chief Executive Officer Terrence A. Duffy sold 15,000 shares on September 10, 2026, for a total value of $4,116,539. Director Elizabeth A. Cook sold 500 shares at $280.11 on September 14, 2026, totaling $140,055. Director William R. Shepard bought 292 shares at $268.76 on September 25, 2026, worth $78,626. Director Martin J. Gepsman sold 400 shares at $302.50 on October 22, 2026, for $121,000.

Analysts Set New Price Targets

On October 22, 2026, UBS maintained a Neutral rating on the stock while raising its price target from $270.00 to $310.00. Morgan Stanley maintained an Overweight rating and lifted its target from $337.00 to $359.00. Barclays maintained an Equal-Weight rating and raised its target from $281.00 to $321.00. Wells Fargo maintained an Overweight rating while moving its target from $315.00 to $333.00. Piper Sandler reiterated an Overweight rating and increased its target from $295.00 to $330.00. The company carries a consensus hold rating and an average price target of $292.94 across 16 analyst opinions.

About CME Group Inc.

CME Group Inc. operates financial exchanges where market participants trade futures and options contracts. Its platform handles products tied to interest rates, equity indexes, foreign exchange, agricultural goods, energy, and metals. The exchange serves institutional traders and commercial hedgers worldwide seeking to manage risk or gain market exposure.

Bottom Line

Investors continue to monitor institutional filings and insider transactions as market conditions shift. Watch for upcoming earnings reports and future SEC disclosures to track how large funds manage their positions in the exchange operator.